Skip to main content
. 2016 Oct 28;17(11):1802. doi: 10.3390/ijms17111802

Table 1.

Mean changes during the study.

Parameters Food Supplement Containing Alpha-Lipoic Acid Placebo
Baseline 3 Months Baseline 3 Months
Number 54 53 51 49
Sex (Male/Female) 26/28 25/28 25/26 24/25
Age (years) 52.5 ± 7.9 53.1 ± 8.2
Smoking status (M/F) 12/10 11/10 13/12 13/12
Height (m) 1.68 ± 0.05 1.69 ± 0.06
Weight (kg) 80.1 ± 7.1 79.8 ± 6.9 80.4 ± 7.3 80.9 ± 7.6
BMI (kg/m2) 28.4 ± 2.5 28.3 ± 2.4 28.1 ± 2.2 28.3 ± 2.4
FPG (mg/dL) 119.5 ± 16.3 102.2 ± 9.6 *,° 122.3 ± 17.1 120.4 ± 16.6
PPG (mg/dL) 164.2 ± 22.1 141.3 ± 18.4 *,° 162.3 ± 21.2 159.1 ± 19.8
HbA1c (%) 7.8 ± 0.4 7.2 ± 0.3 *,° 7.9 ± 0.5 7.7 ± 0.3
FPI (µU/mL) 11.1 ± 3.6 10.6 ± 3.3 10.2 ± 2.6 10.4 ± 2.8
HOMA-IR 3.26 ± 1.86 2.67 ± 1.23 *,° 3.08 ± 1.64 3.09 ± 1.71
TC (mg/dL) 192.5 ± 17.3 171.3 ± 14.6 *,° 191.7 ± 16.8 193.4 ± 17.7
LDL-C (mg/dL) 123.2 ± 11.5 105.7 ± 9.8 *,° 122.5 ± 11.0 124.9 ± 11.8
HDL-C (mg/dL) 45.7 ± 5.5 46.1 ± 5.7 45.9 ± 5.6 45.6 ± 5.4
Tg (mg/dL) 118.2 ± 25.8 97.4 ± 19.5 *,° 116.5 ± 24.2 114.7 ± 22.2
Hs-CRP (mg/L) 2.3 ± 0.6 1.8 ± 0.3 *,° 2.5 ± 0.8 2.2 ± 0.7
SOD (U/mL) 94.7 ± 19.3 111.4 ± 24.9 *,° 96.2 ± 21.4 98.1 ± 22.3
GSH-Px (EE/U) 97.2 ± 39.8 119.6 ± 43.3 *,° 93.7 ± 36.5 94.4 ± 35.1
MDA (nmol/mL) 42.8 ± 18.5 33.9 ± 14.8 *,° 44.6 ± 22.7 41.5 ± 20.8

Data are expressed as mean ± standard deviation; * p < 0.05 vs. baseline; ° p < 0.05 vs. placebo. BMI: body mass index; FPG: fasting plasma glucose; PPG: post-prandial-glucose; HbA1c: glycated hemoglobin; FPI: fasting plasma insulin; HOMA-IR: HOMA-index; TC: total cholesterol; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; Tg: triglycerides; Hs-CRP: high sensitivity C-reactive protein; SOD: superoxide dismutase; GSH-Px: glutathione peroxidase; MDA: malondialdehyde.